Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125193783 | 12519378 | 3 | F | 201512 | 20160831 | 20160630 | 20160912 | PER | US-ELI_LILLY_AND_COMPANY-US201606009301 | ELI LILLY AND CO | 0.00 | M | Y | 0.00000 | 20160912 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125193783 | 12519378 | 1 | PS | HUMALOG MIX75/25 | INSULIN LISPRO | 1 | Subcutaneous | 20 U, BID | Y | U | 20563 | 20 | IU | INJECTION | BID | ||||
| 125193783 | 12519378 | 2 | SS | HUMALOG MIX75/25 | INSULIN LISPRO | 1 | Subcutaneous | 10 U, BID | Y | U | C506934M | 20563 | 10 | IU | INJECTION | BID | |||
| 125193783 | 12519378 | 3 | SS | GLIPIZIDE. | GLIPIZIDE | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 125193783 | 12519378 | 4 | SS | ACTOPLUS MET | METFORMIN HYDROCHLORIDEPIOGLITAZONE HYDROCHLORIDE | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 125193783 | 12519378 | 5 | C | ANDROGEL | TESTOSTERONE | 1 | Transdermal | 50 MG, QD | U | 0 | 50 | MG | QD | ||||||
| 125193783 | 12519378 | 6 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | Oral | 81 MG, QD | U | 0 | 81 | MG | TABLET | QD | |||||
| 125193783 | 12519378 | 7 | C | ASTEPRO | AZELASTINE HYDROCHLORIDE | 1 | Nasal | 2 DF, QD | U | 0 | 2 | DF | QD | ||||||
| 125193783 | 12519378 | 8 | C | CLARITIN | LORATADINE | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | TABLET | QD | |||||
| 125193783 | 12519378 | 9 | C | DESONIDE. | DESONIDE | 1 | Topical | UNK, BID | U | 0 | CREAM | BID | |||||||
| 125193783 | 12519378 | 10 | C | ENALAPRIL MALEATE. | ENALAPRIL MALEATE | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | TABLET | QD | |||||
| 125193783 | 12519378 | 11 | C | FLONASE /00908302/ | MOMETASONE FUROATE | 1 | Nasal | 2 DF, QD | U | 0 | 2 | DF | QD | ||||||
| 125193783 | 12519378 | 12 | C | FLUOCINONIDE. | FLUOCINONIDE | 1 | Topical | UNK, BID | U | 0 | BID | ||||||||
| 125193783 | 12519378 | 13 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 20 MG, EACH MORNING | U | 0 | 20 | MG | TABLET | QD | |||||
| 125193783 | 12519378 | 14 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 40 MG, EACH EVENING | U | 0 | 40 | MG | TABLET | QD | |||||
| 125193783 | 12519378 | 15 | C | LOPRESSOR | METOPROLOL TARTRATE | 1 | Oral | 50 MG, QD | U | 0 | 50 | MG | TABLET | QD | |||||
| 125193783 | 12519378 | 16 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, QD | U | 0 | 40 | MG | CAPSULE | QD | |||||
| 125193783 | 12519378 | 17 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 10 MG, EACH MORNING | U | 0 | 10 | MG | TABLET | QD | |||||
| 125193783 | 12519378 | 18 | C | NYSTATIN/TRIAMCINOLONE | NYSTATINTRIAMCINOLONE | 1 | Topical | UNK, BID | U | 0 | CREAM | BID | |||||||
| 125193783 | 12519378 | 19 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 0.175 MG, QD | U | 0 | .175 | MG | TABLET | QD | |||||
| 125193783 | 12519378 | 20 | C | ULTRACET | ACETAMINOPHENTRAMADOL HYDROCHLORIDE | 1 | Oral | 1 DF, BID | U | 0 | 1 | DF | TABLET | BID | |||||
| 125193783 | 12519378 | 21 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | Oral | 300 MG, EACH MORNING | U | 0 | 300 | MG | TABLET | QD | |||||
| 125193783 | 12519378 | 22 | C | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | 15 MG, TID | U | 0 | 15 | MG | TABLET | TID | |||||
| 125193783 | 12519378 | 23 | C | METFORMINE HCL | METFORMIN HYDROCHLORIDE | 1 | Oral | 850 MG, TID | U | 0 | 850 | MG | TABLET | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125193783 | 12519378 | 1 | Type 2 diabetes mellitus |
| 125193783 | 12519378 | 3 | Product used for unknown indication |
| 125193783 | 12519378 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125193783 | 12519378 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125193783 | 12519378 | Blood glucose decreased | |
| 125193783 | 12519378 | Blood glucose increased | |
| 125193783 | 12519378 | Hypoglycaemia | |
| 125193783 | 12519378 | Tremor | |
| 125193783 | 12519378 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125193783 | 12519378 | 1 | 2011 | 0 |